Newsfeeds Archive - Page 2 of 5

3 minute read

Earnings

Earnings Scheduled For November 30, 2023

November 30, 7:08 AM

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its third quarter. • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.45 per share on revenue of $249.41 million.

AMBA

1 minute read

Movers

12 Industrials Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

November 29, 5:31 PM

Gainers BioNexus Gene Lab (NASDAQ:BGLC) shares increased by 40.4% to $1.53 during Wednesday’s after-market session. The company’s market…

AUVI

3 minute read

Titan Machinery Inc. Announces Leadership Succession To Drive Next Phase Of Growth; President And COO Bryan Knutson To Become President And CEO; Chairman And CEO David Meyer To Assume Role Of Executive Chairman

By Benzinga Newsdesk

October 18, 8:18 AM

President and COO Bryan Knutson to Become President and CEO Chairman and CEO David Meyer to Assume Role of Executive ChairmanTitan Machinery Inc. (NASDAQ:TITN) (the "Company"), a leading network of full-service

TITN

22 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

October 4, 12:01 PM

On Wednesday, 311 stocks hit new 52-week lows.

AADI

4 minute read

Why Lands’ End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

August 31, 12:50 PM

Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer stockholders of up to $91 million.

ACER

2 minute read

Signet Jewelers, Shopify, Ciena And Other Big Stocks Moving Higher On Thursday

By Lisa Levin

August 31, 11:28 AM

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session. Canopy Growth Corporation (NASDAQ: CGC) jumped 31% to $0.59 after the HHS called for moving marijuana to a lower-risk drug category.

ANGI